24,054 results match your criteria: "Gemcitabine"

S
Soft Extrudable Dendritic Particles with Nanostructured Tendrils for Local Adhesion and Drug Release to Bladder Cancers.
Jin Gyun Lee, Joseph Petraccione, Katherine A Trese, Alex C Hughes, Taylor R Ausec

Adv Mater· September 2025

Videos about Article: user user

2 13 5 14

View All Article and Social Media Activity
I
Inhibition of pancreatic cancer and potentiation of gemcitabine effects by the extract of Pao Pereira.
Jun Yu, Jeanne Drisko, Qi Chen

Oncol Rep· July 2013

Videos about Article: user user user

2 1 1

View All Article and Social Media Activity
F
First-line atezolizumab monotherapy vs. single-agent chemotherapy in patients with advanced or metastatic non-small cell lung cancer who are ineligible for platinum-based therapy: Analysis of the IPSOS Asian subpopulation.
Baohui Han, Solange Peters, Anh Tuan Le, Dingzhi Huang, Gang Wu

Chin Med J (Engl)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1b/2 study of first-line anti-PD-L1/ TGF-βRII fusion protein SHR-1701 combined with nab-paclitaxel and gemcitabine for advanced pancreatic ductal adenocarcinoma.
Ran Xue, Miaoyan Wei, Jiajia Yuan, Zhihua Li, Yuhong Zhou

Signal Transduct Target Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bacillus Calmette-Guérin-exposed Non-muscle-invasive Bladder Cancer: Survival Benchmarks, Bladder-sparing Strategies, and Implications for Trial Design.
Seyed Behzad Jazayeri, Renzo G DiNatale, Christopher Guske, Christian Harrs, Joshua Linscott

Eur Urol Focus· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigating the causality and pathogenesis of multiple sclerosis in breast cancer via bioinformatics analysis.
Yanfeng Wang, Haitao Ji, Huxia Wang, Zhangjun Song

Mult Scler Relat Disord· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel prognostic model for lung squamous cell carcinoma based on multi-omics analysis and machine learning.
Jian Li, Zengqiang Shen, Dabei Liu, Jun Ma

PLoS One· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biology-driven stratification of advanced biliary tract cancer treated with nab-paclitaxel plus gemcitabine-cisplatin: A prospective observational cohort study.
Seonjeong Woo, Beodeul Kang, Sung Hwan Lee, Jung Sun Kim, Haeyoun Kang

Hepatology· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Postoperative outcomes and role of adjuvant therapy in common bile duct cancer].
A N Polyakov, Yu I Patyutko, A G Kotelnikov, I S Bazin, A Yu Syskova

Khirurgiia (Mosk)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intensified radiochemotherapy with cisplatin and gemcitabine for cervical cancer in the modern era: a retrospective cohort study.
Elena Riggenbach, Lucas Mose, Sara Imboden, Franziska Siegenthaler, Elke Krause

J Gynecol Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Harnessing Artificial Intelligence for Risk Stratification and Outcome Prediction in Urologic Cancers: A Systematic Review.
Navid Roessler, Marcin Miszczyk, Keiichiro Miyajima, Alessandro Dematteis, Ahmed R Alfarhan

Eur Urol Focus· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proposal of limit values for surface contamination by cytotoxic drugs in pharmacies and hospitals.
Lenka Doležalová, Lucie Bláhová, Jan Kuta, Tereza Hojdarová, Luděk Bláha

Ceska Slov Farm· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gemcitabine-cisplatin chemotherapy plus anti-PD-L1 therapy reinvigorates antitumor immune response by reprogramming the intrahepatic cholangiocarcinoma microenvironment.
Yang Song, Shao-Wei Huang, Bo Shu, Ying-Xia Zhou, Wei-Dong Dai

Front Immunol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generate shows nab-paclitaxel plus gemcitabine still an effective regimen for metastatic pancreatic cancer: In this study, mFOLFIRINOX and S-IROX did not demonstrate superior outcomes compared to GnP in patients aged 75 years or younger with metastatic pancreatic cancer.
Leah Lawrence

Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-gallbladder cancer activities and toxicity studies of glycyrrhetinic acid derivative as a novel PPARγ agonist.
Min Liu, Haizhang Ma, Gaozhong Xiong, Mei Qi, Yuan Xia

Front Immunol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Niclosamide nanoparticles enhance pancreatic cancer sensitivity to gemcitabine via HIF-1α inhibition.
Susheel Kumar Nethi, Venugopal Gunda, Nagabhishek Sirpu Natesh, Brianna M White, Adam S Mullis

iScience· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Response to Avelumab Maintenance Therapy and Durable Remission After Cessation in a Patient With Metastatic Urothelial Carcinoma of the Renal Pelvis: A Case Report.
Hiroyuki Fujinami, Shinro Hata, Toru Inoue, Tadasuke Ando, Toshitaka Shin

IJU Case Rep· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CUL2 confers ferroptosis resistance in pancreatic cancer by disrupting KEAP1-mediated NRF2 degradation.
Kui Yu, LiLi Chen, Yong Zhong, Yang Wang, Na Zhu

Cancer Cell Int· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual pH-Responsive Calcium Phosphate Nanoparticles Conjugated with Folate by CuAAC Click Chemistry for Targeted Gemcitabine Delivery to Cancer Cells.
Thales R Machado, Aileen Winter, Kateryna Loza, Kathrin Kostka, Valtencir Zucolotto

ACS Appl Bio Mater· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case of successfully completed robot-assisted distal pancreatectomy for pancreatic tail cancer in a patient with prior colostomy: case report.
Taro Sakurai, Kazuto Shibuya, Mina Fukasawa, Katsuhisa Hirano, Toru Watanabe

Int Cancer Conf J· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant chemoradiotherapy plus programmed cell death protein-1 blockade versus chemoradiotherapy alone for muscle-invasive bladder cancer: a real-world comparative study.
Fan Zhang, Jingsuo Wang, Yanhang Yu, Chuanao Zhang, Jun Ouyang

Front Immunol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated multi-omics elucidates knockdown-mediated chemosensitization to gemcitabine in pancreatic ductal adenocarcinoma.
Bing Qi, Yuwei Wu, Ning Wang, Liumeng Duan, Yangbo Wei

Front Immunol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synergistic anti-tumor activity of the mTOR inhibitor everolimus and gemcitabine for relapsed/refractory peripheral T cell lymphoma.
Ling Huang, Hanguo Guo, Yan Teng, Diwen Pang, Fen Zhang

Front Immunol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modular Design of Mesoporous Silica Nanoparticles Enables Bioimaging, Dual Chemotherapy, and Combinatorial Gene Silencing in Triple-Negative Breast Cancer.
Laura P Rebolledo, Punnya Anil Kumar Jeeja, Leyla Danai, Tamanna Binte Huq, Kirill A Afonin

ACS Appl Mater Interfaces· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting E2F8 sensitizes gemcitabine-resistant gallbladder cancer to PARP inhibitors by disrupting RRM2-driven DNA repair.
Xiaojian Ni, Min Li, Wenqing Qiu, Jichang Han, Meng Yu

J Exp Clin Cancer Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advanced Ampullary Cancer: post-hoc analysis of the ABC-01, -02 and -03 clinical trials.
Angela Lamarca, Paul Ross, Harpreet S Wasan, Richard A Hubner, Mairéad G McNamara

Oncologist· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment landscape from first- to third-line therapy and quality of life data of patients with pancreatic cancer from the prospective German PARAGON (Platform for Outcome, Quality of Life, and Translational Research on Pancreatic Cancer) registry (IKF-PARAGON study).
Thorsten O Goetze, Salah-Eddin Al-Batran, Ruediger Liersch, Lars Scheuer, Thomas Goehler

Int J Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-stromal crosstalk and macrophage enrichment are associated with chemotherapy response in bladder cancer.
Sophie Leypold, Janik Riese, Lancelot Seillier, Mark Kühnel, Julia Pannhausen

FEBS Open Bio· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of microbubble-assisted gemcitabine delivery with repeated ultrasound exposure in a pancreatic cancer organ-on-a-chip model.
Delanyo Kpeglo, Malcolm Haddrick, Margaret A Knowles, Stephen D Evans, Sally A Peyman

Sci Rep· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis